New web tool helps cancer patients alert relatives about genetic risks

NCT ID NCT05552664

Completed Knowledge-focused Sponsor: University of Michigan Rogel Cancer Center Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study tested a web-based program called GIFT that helps cancer patients share information about inherited cancer risks with their relatives. Over 3,000 patients and their family members took part. The goal was to see if the tool encourages more relatives to get genetic testing and talk to their doctors about cancer prevention.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: web-based family communication program
What this could lead to: If successful, this approach could help more families learn about their inherited cancer risks and take steps to prevent or catch cancer early.
What could go wrong: This study is observational and does not test a new treatment. The results may not apply to all families or cancer types, and the impact on actual cancer outcomes is unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CANCER

Contacts and locations

Show contact details

Locations

Emory University

Atlanta, Georgia, 30322, United States
Stanford University

Stanford, California, 94305, United States
University of Michigan Rogel Cancer Center

Ann Arbor, Michigan, 48108, United States
University of Southern California

Los Angeles, California, 90007, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.